Sriram S. is an accomplished global market access and commercialization strategy leader with extensive experience in driving end-to-end value and access strategies for high-value therapies. They led the successful global launch of Dupixent across major markets and established market access strategies for multiple pipeline assets. With a strong background in health systems and payer policy trends, Sriram effectively collaborates with cross-functional teams and stakeholders. Currently, they are a Director at Johnson & Johnson and are pursuing advanced degrees at multiple prestigious institutions, including Duke University and the University of Illinois Urbana-Champaign.
This person is not in the org chart
This person is not in any teams
This person is not in any offices